BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36520294)

  • 41. Association between fish oil supplements use and serum per- and polyfluoroalkyl substances (PFAS): Results from the National Health and Nutrition Examination Survey.
    Onteeru M; Barnes LE; O'Connell K; Bhimani J; Du M; Romano ME; Kantor ED
    Environ Res; 2022 Dec; 215(Pt 1):114205. PubMed ID: 36049507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exposure to per- and polyfluoroalkyl substances and glycemic control in older US adults with type 2 diabetes mellitus.
    Brosset E; Ngueta G
    Environ Res; 2023 Jan; 216(Pt 3):114697. PubMed ID: 36334831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased levels of perfluoroalkyl substances in patients receiving hemodialysis treatment.
    Huang JK; Chuang YS; Wu PH; Tai CJ; Lin JR; Kuo MC; Chiu YW; Hsu PC; Wu MT; Salihovic S; Lin YT
    Sci Total Environ; 2023 Oct; 896():165184. PubMed ID: 37391133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
    Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
    Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biomarkers of poly- and perfluoroalkyl substances (PFAS) in Sub-Arctic and Arctic communities in Canada.
    Garcia-Barrios J; Drysdale M; Ratelle M; Gaudreau É; LeBlanc A; Gamberg M; Laird BD
    Int J Hyg Environ Health; 2021 Jun; 235():113754. PubMed ID: 33984600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women.
    Ren Y; Jin L; Yang F; Liang H; Zhang Z; Du J; Song X; Miao M; Yuan W
    Environ Health; 2020 Aug; 19(1):88. PubMed ID: 32807188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
    Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
    Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prenatal plasma concentrations of Perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age.
    Niu J; Liang H; Tian Y; Yuan W; Xiao H; Hu H; Sun X; Song X; Wen S; Yang L; Ren Y; Miao M
    Environ Health; 2019 Jun; 18(1):53. PubMed ID: 31196101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Associations of exposure to perfluoroalkyl substances with serum uric acid change and hyperuricemia among Chinese women: Results from a longitudinal study.
    Feng Y; Fu M; Guan X; Wang C; Meng H; Zhou Y; He M; Guo H
    Chemosphere; 2022 Dec; 308(Pt 3):136438. PubMed ID: 36116625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
    Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
    Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
    Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
    Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association between blood PFAS concentrations and clinical biochemical measures of organ function and metabolism in participants of the Canadian Health Measures Survey (CHMS).
    Cakmak S; Lukina A; Karthikeyan S; Atlas E; Dales R
    Sci Total Environ; 2022 Jun; 827():153900. PubMed ID: 35218824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast cancer risk and serum levels of per- and poly-fluoroalkyl substances: a case-control study nested in the California Teachers Study.
    Hurley S; Goldberg D; Wang M; Park JS; Petreas M; Bernstein L; Anton-Culver H; Nelson DO; Reynolds P
    Environ Health; 2018 Nov; 17(1):83. PubMed ID: 30482205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomonitoring of perfluoroalkyl and polyfluoroalkyl substances (PFAS) from the Survey of the Health of Wisconsin (SHOW) 2014-2016 and comparison with the National Health and Nutrition Examination Survey (NHANES).
    Schultz AA; Stanton N; Shelton B; Pomazal R; Lange MA; Irving R; Meiman J; Malecki KC
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):766-777. PubMed ID: 37580384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Associations between apolipoprotein B and selected perfluoroalkyl substances among diabetics and nondiabetics.
    Jain RB; Ducatman A
    Environ Sci Pollut Res Int; 2021 Mar; 28(11):13819-13828. PubMed ID: 33196992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human serum poly- and perfluoroalkyl substance concentrations and their associations with gestational diabetes mellitus.
    Zhang Y; Chen R; Gao Y; Qu J; Wang Z; Zhao M; Bai X; Jin H
    Environ Pollut; 2023 Jan; 317():120833. PubMed ID: 36493933
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perfluoroalkyl substances, airways infections, allergy and asthma related health outcomes - implications of gender, exposure period and study design.
    Kvalem HE; Nygaard UC; Lødrup Carlsen KC; Carlsen KH; Haug LS; Granum B
    Environ Int; 2020 Jan; 134():105259. PubMed ID: 31733527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma perfluoroalkyls are associated with decreased levels of proteomic inflammatory markers in a cross-sectional study of an elderly population.
    Salihovic S; Lind L; Larsson A; Lind PM
    Environ Int; 2020 Dec; 145():106099. PubMed ID: 32916415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Demographic, life-style and physiological determinants of serum per- and polyfluoroalkyl substance (PFAS) concentrations in a national cross-sectional survey of Swedish adolescents.
    Nyström J; Benskin JP; Plassmann M; Sandblom O; Glynn A; Lampa E; Gyllenhammar I; Moraeus L; Lignell S
    Environ Res; 2022 May; 208():112674. PubMed ID: 34998808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral contraceptive use as a determinant of plasma concentrations of perfluoroalkyl substances among women in the Norwegian Mother and Child Cohort (MoBa) study.
    Rush EL; Singer AB; Longnecker MP; Haug LS; Sabaredzovic A; Symanski E; Whitworth KW
    Environ Int; 2018 Mar; 112():156-164. PubMed ID: 29274593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.